Publisher Correction to: ISIS 449884 Injection Add‑On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double‑Blind, Placebo‑Controlled, Phase II Clinical Study Linong JiLeili GaoLi-Ming Gan Publisher Correction Open access 29 August 2024
Insights into Knowledge and Attitudes About Autoantibody Screening from People Affected by Type 1 Diabetes: A Brief Report Caitlin S. KellyWendy A. WolfJessica L. Dunne Brief Report Open access 27 August 2024
Targeting Autophagy: A Promising Therapeutic Strategy for Diabetes Mellitus and Diabetic Nephropathy Qi-Rui LiHui-Ying XuMei-Juan Chen Review Open access 21 August 2024
The Association of HbA1c Variability with 12 Week and 12 Month Outcomes on Diabetes Related Foot Ulcer Healing Georgia ThomasonCatherine GoodayKetan Dhatariya Original Research Open access 17 August 2024
A Randomized Controlled Trial on the Effect of Luseogliflozin on Bone Microarchitecture Evaluated Using HR-pQCT in Elderly Type 2 Diabetes Riyoko ShigenoIchiro HorieNorio Abiru Brief Report Open access 17 August 2024
Correction to: Safety and Psychological Outcomes of Tandem t:Slim X2 Insulin Pump with Control-IQ Technology in Children, Adolescents, and Young Adults with Type 1 Diabetes: A Systematic Review Chiara MameliGiulia Marie SmylieMaurizio Delvecchio Correction Open access 14 August 2024
Transition from Paediatric to Adult Diabetes Care in People with Type 1 Diabetes: An Online Survey from France Juliette EroukhmanoffClaire Ballot SchmitEric Renard Original Research Open access 10 August 2024
Forecasting Trial Milestones: A Predictive Analysis for Early Termination of the SOUL Study Binayak SinhaSamit Ghosal Original Research Open access 08 August 2024
Efficacy and Safety of Escalating the Dose of Oral Semaglutide from 7 to 14 mg: A Single-Center, Retrospective Observational Study Genki SatoHiroshi UchinoTakahisa Hirose Original Research Open access 07 August 2024 Pages: 2119 - 2130
Flash Glucose Monitoring is Associated with HbA1c Improvement in Type 2 Diabetes Managed with Multiple Daily Injections of Insulin in the UK: A Retrospective Observational Study Karen A. AdamsonFraser W. GibbAnna Strzelecka Original Research Open access 05 August 2024 Pages: 2109 - 2118
Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies Akshay B. JainValerie Lai Review Open access 31 July 2024 Pages: 2001 - 2025
Tirzepatide: A Double Agonist for Various People Living with Type 2 Diabetes Felice StrolloGiuseppina GuarinoSandro Gentile Commentary Open access 31 July 2024 Pages: 1855 - 1860
Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications Rafael ZubiránIvette Cruz-BautistaCarlos A. Aguilar-Salinas Review Open access 30 July 2024 Pages: 1979 - 2000
The Effects of Bariatric Surgery on the Requirement for Antihypertensive Treatment in Type 2 Diabetes: Insights from a Long-Term Follow-Up Study Adrian HealdFahmida MannanHandrean Soran Original Research Open access 27 July 2024 Pages: 2097 - 2107
PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice Sergiu-Bogdan CatrinaHanan AmadidStefan Jansson Original Research Open access 25 July 2024 Pages: 2079 - 2095
Effect of Replacing Sucrose in Beverages with Nonnutritive Sweetener Sucralose on Cardiometabolic Risk Factors Among Asian Indian Adults with Type 2 Diabetes: A 12-Week Randomized Controlled Trial Viswanathan MohanValangaiman Sriram ManasaVasudevan Sudha Original Research Open access 24 July 2024 Pages: 2061 - 2077
Intentional Insulin Overdose and Depression in Subjects with and Without Diabetes Mellitus: A Commentary Evanthia GouveriAikaterini GkouveriNikolaos Papanas Commentary Open access 24 July 2024 Pages: 1845 - 1854
Suitability and Usefulness of a Flexible Dosing Timing of Oral Semaglutide to Maximize Benefit in Clinical Practice: An Expert Panel Riccardo CandidoChiara Di LoretoGian Paolo Fadini Review Open access 22 July 2024 Pages: 1963 - 1977
Summary of Research: Cardiovascular and Kidney Outcomes with Finerenone in Patients with Type 2 Diabetes and Chronic Kidney Disease—The FIDELITY Pooled Analysis Karin HumleBoris KlangerNichole Jefferson Summary of Research Open access 19 July 2024 Pages: 1861 - 1864
Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review Subodh VermaLawrence A. LeiterMarc P. Bonaca Review Open access 18 July 2024 Pages: 1893 - 1961
Correction to: Basal Insulinotherapy in Patients Living with Diabetes in France: The EF-BI Study Pierre GourdyPatrice DarmonAlfred Penfornis Correction Open access 15 July 2024 Pages: 2131 - 2132
Tirzepatide Improved Health-Related Quality of Life Compared with Insulin Lispro in Basal Insulin-Treated Adults with Type 2 Diabetes and Inadequate Glycaemic Control: A Randomised Controlled Phase 3b Trial (SURPASS-6) Kristina Secnik BoyeJiat Ling PoonHiren Patel Original Research Open access 15 July 2024 Pages: 2039 - 2059
Association of Changes in A1C Following Continuous Glucose Monitoring Acquisition in People with Sub-Optimally Treated Type 2 Diabetes Taking GLP-1 RA Therapy Eden MillerJoyce S. ChuangEugene E. Wright Jr. Original Research Open access 15 July 2024 Pages: 2027 - 2038
ISIS 449884 Injection Add-On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Study Linong JiLeili GaoLi-Ming Gan Original Research Open access 15 July 2024
Safety and Psychological Outcomes of Tandem t:Slim X2 Insulin Pump with Control-IQ Technology in Children, Adolescents, and Young Adults with Type 1 Diabetes: A Systematic Review Chiara MameliGiulia Marie SmylieMaurizio Delvecchio Review Open access 15 July 2024
Modern Management of Cardiometabolic Continuum: From Overweight/Obesity to Prediabetes/Type 2 Diabetes Mellitus. Recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group Andrej JanezEmir MuzurovicManfredi Rizzo Review Open access 11 July 2024 Pages: 1865 - 1892
Evaluation of Cardiovascular Risk in People with Type 1 Diabetes: A Comprehensive and Specific Proposed Practical Approach Clara ViñalsIgnacio CongetAntonio J. Amor Practical Approach Open access 08 July 2024 Pages: 1831 - 1844
Risk of Urogenital Bacterial Infection with Sodium-Glucose Cotransporter-2 Inhibitors: A Retrospective Cohort Study Using a Claims Database Takanori ImaiNaoto KatoShuji Hatakeyama Original Research Open access 03 July 2024 Pages: 1821 - 1830
Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review Ibrahim SahinOkan BakinerAysegul Atmaca Review Open access 27 June 2024 Pages: 1687 - 1716
Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification Martin HaluzikZoltan TaybaniMaciej Malecki Review Open access 27 June 2024 Pages: 1673 - 1685
Impact of Initial Treatment Policies on Long-term Complications and Costs in Japanese Patients with Type 2 Diabetes: A Real-World Database Study Hiroshi YoshiharaTohru TonoikeAtaru Igarashi Original Research Open access 25 June 2024 Pages: 1811 - 1820
Triglyceride Glucose Index for the Detection of Diabetic Kidney Disease and Diabetic Peripheral Neuropathy in Hospitalized Patients with Type 2 Diabetes Zhihui TuJuan DuShan Huang Original Research Open access 22 June 2024 Pages: 1799 - 1810
Frequency and Severity of Hypoglycemia Under Conditions of Increased Hypoglycemic Risk with Insulin Efsitora Alfa Versus Insulin Glargine Treatment in Participants with Type 2 Diabetes Tim HeiseGrit AndersenRichard M. Bergenstal Original Research Open access 22 June 2024 Pages: 1785 - 1797
Perspective of Continuous Glucose Monitoring-Based Interventions at the Various Stages of Type 2 Diabetes R. A. AjjanS. SeiduJ. P. Riveline Commentary Open access 22 June 2024 Pages: 1657 - 1672
Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL) with or Without Pre-prandial Insulin in Pre-treated Subphenotypes of Type 2 Diabetes: Insights from a Post Hoc Analysis Wolfgang LandgrafDavid R. OwensGeremia B. Bolli Original Research Open access 15 June 2024 Pages: 1769 - 1784
Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study William van HoutumPatrick SchrömbgesHans Herrings Original Research Open access 11 June 2024 Pages: 1749 - 1768
Perspectives and Behaviors of People with Diabetes toward Time in Range and Glucose Control in Diabetes Management: An Online Survey Christophe De BlockAlice Y. Y. ChengAnna Ginovker Original Research Open access 11 June 2024 Pages: 1735 - 1747
Adverse Events of Oral GLP-1 Receptor Agonist (Semaglutide Tablets): A Real-World Study Based on FAERS from 2019 to 2023 Si XiongRuoyu GouJunan Chen Original Research Open access 22 May 2024 Pages: 1717 - 1733
Analysis of Distribution and Drug Susceptibility Test Results of Pathogenic Bacteria in Diabetic Foot Ulcers Man WuFangting GuoFengxiong Wang Original Research Open access 21 May 2024 Pages: 1627 - 1637
The Efficacy and Safety of Sodium-Glucose Co-transporter 2 (SGLT2) Inhibitors in Real-World Clinical Practice: Potential Cautionary Use in Elderly Patients with Type 2 Diabetes (T2D) Dong-Hwa LeeJi Hwan OhTae Keun Oh Original Research Open access 21 May 2024 Pages: 1615 - 1626
Urban–Rural Differences in the Prevalence of Diabetes Among Adults in Haryana, India: The ICMR-INDIAB Study (ICMR-INDIAB-18) Sanjay KalraRanjit Mohan AnjanaViswanathan Mohan Original Research Open access 21 May 2024 Pages: 1597 - 1613
Addressing the Burden of Multiple Daily Insulin Injections in Type 2 Diabetes with Insulin Pump Technology: A Narrative Review Diana BrixnerSteven V. EdelmanJames R. Gavin III Review Open access 21 May 2024 Pages: 1525 - 1534
Therapy-Related Satisfaction and Quality of Life for Japanese People with Diabetes Using Rapid-Acting Insulin Analogs: A Web-Based Survey Hitoshi IshiiYasutaka MaedaMakoto Imori Original Research Open access 18 May 2024 Pages: 1577 - 1595
Efficacy of Self-Review of Lifestyle Behaviors with Once-Weekly Glycated Albumin Measurement in People with Type 2 Diabetes: A Randomized Pilot Study Hideaki JinnouchiAkira YoshidaKoshin Sekimizu Original Research Open access 16 May 2024 Pages: 1561 - 1575
Changes in Basal and Bolus Insulin Requirements with Tirzepatide as an Adjunctive Therapy in Adults with Type 1 Diabetes Using Tandem Control-IQ Kagan E. KarakusMatthew P. KleinViral N. Shah Brief Report Open access 14 May 2024 Pages: 1647 - 1655
Could Online Education Replace Face-to-Face Education in Diabetes? A Systematic Review Núria Alonso-CarrilSilvia Rodriguez-RodríguezVerónica Perea Review Open access 14 May 2024 Pages: 1513 - 1524
Counseling for Insulin Icodec: A Proposed Practitioner’s Guide Sanjay KalraSaptarshi BhattacharyaNitin Kapoor Commentary Open access 14 May 2024 Pages: 1491 - 1499
Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study David M. WilliamsBarbara-Alex AlbertsThinzar Min Brief Report Open access 09 May 2024 Pages: 1639 - 1646
Real-World Treatment Patterns Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide Caroline SwiftMonica S. FrazerMico Guevarra Original Research Open access 09 May 2024 Pages: 1547 - 1559
Use of Tirzepatide in Adults with Type 2 Diabetes Mellitus: Scientific Evidence and Practical Aspects Luis A. VázquezSantiago Tofé-PovedanoEsteban Jódar-Gimeno Review Open access 09 May 2024 Pages: 1501 - 1512
